Vacuolar H+-ATPase meets glycosylation in patients with cutis laxa |
| |
Authors: | Mailys Guillard Aikaterini Dimopoulou Björn Fischer Eva Morava Dirk J. Lefeber Uwe Kornak Ron A. Wevers |
| |
Affiliation: | 1. Laboratory of Pediatrics and Neurology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands;2. Institute for Medical Genetics, Charité Universitaetsmedizin Berlin, Campus Virchow Augustenburger Platz 1, 13353 Berlin, Germany;3. Department of Pediatrics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands;4. Max Planck Institute for Molecular Genetics, Berlin, Germany |
| |
Abstract: | Glycosylation of proteins is one of the most important post-translational modifications. Defects in the glycan biosynthesis result in congenital malformation syndromes, also known as congenital disorders of glycosylation (CDG). Based on the iso-electric focusing patterns of plasma transferrin and apolipoprotein C-III a combined defect in N- and O-glycosylation was identified in patients with autosomal recessive cutis laxa type II (ARCL II). Disease-causing mutations were identified in the ATP6V0A2 gene, encoding the a2 subunit of the vacuolar H+-ATPase (V-ATPase). The V-ATPases are multi-subunit, ATP-dependent proton pumps located in membranes of cells and organels. In this article, we describe the structure, function and regulation of the V-ATPase and the phenotypes currently known to result from V-ATPase mutations. A clinical overview of cutis laxa syndromes is presented with a focus on ARCL II. Finally, the relationship between ATP6V0A2 mutations, the glycosylation defect and the ARCLII phenotype is discussed. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|